Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
June 7th, 2024
Close Date
October 11th, 2024
Opportunity No.
RFA-CA-24-027

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) has posted a grant opportunity titled "Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)". This grant aims to support multi-level intervention studies that address individual and system level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal is to develop and test interventions and strategies that promote high-quality transitional care and continued engagement of survivors to ensure they receive appropriate surveillance and care into adulthood. The research funded through this grant will provide critical evidence for establishing best practices and standards of care that can be widely disseminated and adopted. For more information, visit the NIH Grants website.

Description

Through this Funding Opportunity Announcement (FOA), the NCI intends to support multi-level intervention studies that address individual and system level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal of this opportunity is to support the development and testing of interventions and strategies that promote high-quality transitional care and continued engagement of survivors of childhood and adolescent cancers to ensure these survivors receive appropriate surveillance and care into adulthood. Overall, it is anticipated that this research will provide critical evidence for establishing best practices and standards of care that can be widely disseminated and adopted.

Contact Information

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a funding opportunity announcement (FOA) for addressing barriers to healthcare transitions for survivors of childhood and adolescent cancers. This FOA aims to support multi-level intervention studies that address individual and system level barriers to transitions from pediatric to adult care for these survivors. The goal is to develop and test interventions and strategies that promote high-quality transitional care and continued engagement of survivors to ensure appropriate surveillance and care into adulthood. The anticipated outcome of this research is to establish best practices and standards of care that can be widely disseminated and adopted. The FOA is associated with the STAR Reauthorization Act of 2023, which focuses on maximizing and accelerating the availability of promising models of care for pediatric cancer survivors. The FOA is expected to be published in June 2024, with an application due date in October 2024. It will utilize the R01 activity code.
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)". This grant aims to address barriers and facilitators that impede the use or uptake of cancer screening and preventive services in populations that experience health disparities. The interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings and referral to accessible care. The projects are encouraged to collaborate with community partners and service providers. The interventions should target barriers and facilitators at the patient, clinician, healthcare setting, and neighborhood/community levels. For more information and to apply, visit the following link: [Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)](http://grants.nih.gov/grants/guide/pa-files/PAR-23-170.html).
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)". This grant aims to support collaborative research projects that address the adverse effects of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. The projects should focus on identifying the mechanisms of therapy-induced adverse effects, clinically characterizing them, and translating the understanding into therapeutic approaches to prevent or minimize long-term sequelae. The research should include mechanistic studies with translational endpoints and longitudinal clinical phenotyping to identify and validate clinical endpoints for future use in clinical trials evaluating interventions to reduce specific adverse effects. The grant does not require cost sharing or matching and falls under the category of health. The deadline for applications is November 5, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-329.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-329.html).